FDA
-
-
-
-
-
-
-
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
-
-
-
-
-
-
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
-
-
-
-
-
-
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
-
-
-
-
-
-
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $32 at Piper Sandler; 'A Tough 2025 Ahead'
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
-
-
-
-
-
-
-
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

